Due to the over-expression of XPO1 in many cancer cells and its role in exporting tumor suppressor genes such as TP53, development of selective inhibitors of nuclear export (SINEs) that inhibit the nuclear export activity of XPO1 in malignant cells has garnered increased attention [43, 45]. This evidence concerns the gene TP53 and cancer.